250 related articles for article (PubMed ID: 1562680)
1. Current strategies for treating invasive candidiasis: emphasis on infections in nonneutropenic patients.
Edwards JE; Filler SG
Clin Infect Dis; 1992 Mar; 14 Suppl 1():S106-13. PubMed ID: 1562680
[TBL] [Abstract][Full Text] [Related]
2. The fluconazole era: management of hematogenously disseminated candidiasis in the nonneutropenic patient.
Kramer KM; Skaar DJ; Ackerman BH
Pharmacotherapy; 1997; 17(3):538-48. PubMed ID: 9165556
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology and treatment of hematogenous candidiasis: a Brazilian perspective.
Colombo AL
Braz J Infect Dis; 2000 Jun; 4(3):113-8. PubMed ID: 10934493
[TBL] [Abstract][Full Text] [Related]
4. Failure of therapy with fluconazole for candidal endophthalmitis.
Nomura J; Ruskin J
Clin Infect Dis; 1993 Nov; 17(5):888-9. PubMed ID: 8286632
[TBL] [Abstract][Full Text] [Related]
5. Fluconazole versus amphotericin B in the treatment of hematogenous candidiasis: a matched cohort study.
Anaissie EJ; Vartivarian SE; Abi-Said D; Uzun O; Pinczowski H; Kontoyiannis DP; Khoury P; Papadakis K; Gardner A; Raad II; Gilbreath J; Bodey GP
Am J Med; 1996 Aug; 101(2):170-6. PubMed ID: 8757357
[TBL] [Abstract][Full Text] [Related]
6. [Current treatment of candidemia in non-neutropenic patients. Amphotericin B or fluconazole? A retrospective study of 62 consecutive patients].
Cobo Reinoso P; Aguado García JM; Lumbreras Bermejo C; Pérez Vela JL; Caballero Cubedo R; Sanz Sanz F; Noriega Rodríguez AR
Rev Clin Esp; 1997 Dec; 197(12):799-803. PubMed ID: 9477669
[TBL] [Abstract][Full Text] [Related]
7. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute.
Rex JH; Bennett JE; Sugar AM; Pappas PG; van der Horst CM; Edwards JE; Washburn RG; Scheld WM; Karchmer AW; Dine AP
N Engl J Med; 1994 Nov; 331(20):1325-30. PubMed ID: 7935701
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
Horn DL; Neofytos D; Anaissie EJ; Fishman JA; Steinbach WJ; Olyaei AJ; Marr KA; Pfaller MA; Chang CH; Webster KM
Clin Infect Dis; 2009 Jun; 48(12):1695-703. PubMed ID: 19441981
[TBL] [Abstract][Full Text] [Related]
9. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J
Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
[TBL] [Abstract][Full Text] [Related]
10. Problems and controversies in the management of hematogenous candidiasis.
Uzun O; Anaissie EJ
Clin Infect Dis; 1996 May; 22 Suppl 2():S95-101. PubMed ID: 8722835
[TBL] [Abstract][Full Text] [Related]
11. Candida glabrata fungemia cured by antibiotic-lock therapy: case report and short review.
Angel-Moreno A; Boronat M; Bolaños M; Carrillo A; González S; Pérez Arellano JL
J Infect; 2005 Oct; 51(3):e85-7. PubMed ID: 16230210
[TBL] [Abstract][Full Text] [Related]
12. Early prediction of Candida glabrata fungemia in nonneutropenic critically ill patients.
Cohen Y; Karoubi P; Adrie C; Gauzit R; Marsepoil T; Zarka D; Clec'h C
Crit Care Med; 2010 Mar; 38(3):826-30. PubMed ID: 20042858
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study.
Nguyen MH; Peacock JE; Tanner DC; Morris AJ; Nguyen ML; Snydman DR; Wagener MM; Yu VL
Arch Intern Med; 1995 Dec 11-25; 155(22):2429-35. PubMed ID: 7503601
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis and management of Candida infection syndromes in non-neutropenic patients.
Solomkin JS
New Horiz; 1993 May; 1(2):202-13. PubMed ID: 7922404
[TBL] [Abstract][Full Text] [Related]
15. Severe candidal infections in neutropenic patients.
Swerdloff JN; Filler SG; Edwards JE
Clin Infect Dis; 1993 Nov; 17 Suppl 2():S457-67. PubMed ID: 8274612
[TBL] [Abstract][Full Text] [Related]
16. [Clinical aspects and prognosis of candidemia, a 6-year retrospective study].
Bregenzer T; Evison-Eckstein AC; Frei R; Zimmerli W
Schweiz Med Wochenschr; 1996 Oct; 126(43):1829-33. PubMed ID: 9005522
[TBL] [Abstract][Full Text] [Related]
17. A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects.
Rex JH; Pappas PG; Karchmer AW; Sobel J; Edwards JE; Hadley S; Brass C; Vazquez JA; Chapman SW; Horowitz HW; Zervos M; McKinsey D; Lee J; Babinchak T; Bradsher RW; Cleary JD; Cohen DM; Danziger L; Goldman M; Goodman J; Hilton E; Hyslop NE; Kett DH; Lutz J; Rubin RH; Scheld WM; Schuster M; Simmons B; Stein DK; Washburn RG; Mautner L; Chu TC; Panzer H; Rosenstein RB; Booth J;
Clin Infect Dis; 2003 May; 36(10):1221-8. PubMed ID: 12746765
[TBL] [Abstract][Full Text] [Related]
18. A randomized study comparing fluconazole with amphotericin B/5-flucytosine for the treatment of systemic Candida infections in intensive care patients.
Abele-Horn M; Kopp A; Sternberg U; Ohly A; Dauber A; Russwurm W; Büchinger W; Nagengast O; Emmerling P
Infection; 1996; 24(6):426-32. PubMed ID: 9007589
[TBL] [Abstract][Full Text] [Related]
19. Candidemia: a nosocomial complication in adults with late-stage AIDS.
Launay O; Lortholary O; Bouges-Michel C; Jarrousse B; Bentata M; Guillevin L
Clin Infect Dis; 1998 May; 26(5):1134-41. PubMed ID: 9597242
[TBL] [Abstract][Full Text] [Related]
20. The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy.
Hachem R; Hanna H; Kontoyiannis D; Jiang Y; Raad I
Cancer; 2008 Jun; 112(11):2493-9. PubMed ID: 18412153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
